Ethanol Sclerotherapy Prior to ART

Launched by ANKARA UNIVERSITY · Jul 19, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring whether a procedure called ethanol sclerotherapy can help women with endometriomas—cysts that develop on the ovaries—who are trying to conceive through assisted reproductive technology (ART), such as in vitro fertilization (IVF). The researchers want to find out if this treatment can increase the chances of having a baby and if it can ease symptoms like chronic pelvic pain and menstrual discomfort, as well as improve the overall experience during the egg retrieval process.

To participate in the trial, women between the ages of 18 and 40 with endometriomas between 4 and 10 centimeters in size may be eligible. Participants will be randomly assigned to receive either the ethanol sclerotherapy treatment or no treatment at all before starting their ART cycles. The study is currently looking for participants, and those who join will help determine if this approach can lead to better outcomes in fertility treatment for women facing these challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • AMH\>0.3 ng/ml
• • unilateral/bilateral endometrioma
• • Endometrioma diameter 40-100 mm
• Exclusion Criteria:
• • 3 or more IVF/embryo transfer failure
• • Menstrual cycle abnormalities
• • Male Factor infertility
• • Presence of uterine fibroids
• • Presence of hydrosalpinx
• • Presence of uterine abnormalities
• • Suspicion of malignancy according to International Ovarian Tumor Analysis criteria